MD Anderson applauds court-ordered corrective statements from tobacco industry to educate public about harms of tobacco use
As an institution dedicated to ending cancer, The University of Texas MD Anderson Cancer Center is committed to promoting cancer prevention and therefore supports the ‘corrective statements’ published by tobacco companies as a result of a 2006 judgment by U.S. District Judge Gladys Kessler. The mandated advertisements, which began appearing this week, will be a significant step toward informing Americans about the addictive power of cigarettes...
Six researchers from MD Anderson elected as AAAS Fellows
In recognition of their contributions to basic, translational, and clinical research, six faculty members from The University of Texas...
Quality of care for older Texas patients with colon cancer on the rise, still room for improvement
Research from The University of Texas MD Anderson Cancer Center finds adherence to surgical treatment guidelines has improved significantly...
Seres Therapeutics, MD Anderson Cancer Center, and the Parker Institute for Cancer Immunotherapy Announce a Collaboration to Support the Investigation of Microbiome Therapeutics for Immuno-Oncology
Seres Therapeutics, Inc., The University of Texas MD Anderson Cancer Center and the Parker Institute for Cancer Immunotherapy today announced a collaboration to evaluate the potential of Seres’ microbiome therapies to improve the outcomes of cancer patients treated with currently available immunotherapy.
The collaborators plan to initiate a randomized, placebo-controlled clinical study at MD Anderson, sponsored by the...
Thousands support MD Anderson’s Boot Walk to End Cancer®
Thousands of patients, family members, volunteers, friends and employees of The University of Texas MD Anderson Cancer Center participated...
Seven leaders join MD Anderson Cancer Center Board of Visitors
The University of Texas MD Anderson Cancer Center Board of Visitors (BOV) welcomed seven new members at its annual meeting today. They include...
Chronic stress hormones may promote resistance to EGFR inhibitors in lung cancer patients
Elevated levels of chronic stress hormones, such as those produced by psychological distress, may promote resistance to drugs commonly used...
Circulating tumor cells associated with relapse in late-stage melanoma patients
A study revealing a connection between circulating tumor cells (CTCs) and relapse in stage IV melanoma patients points to liquid biopsy as...
MD Anderson’s Moon Shots Program celebrates five-year anniversary
The University of Texas MD Anderson Cancer Center celebrates the five-year anniversary of its Moon Shots Program™, a collaborative effort...
Bacteria in the gut modulates response to immunotherapy in melanoma
Bacteria that live in the human digestive tract can influence how cancer responds to immunotherapy, opening a new avenue for research to improve...
Sarah Ann Roder receives MD Anderson’s highest nursing honor
Sarah Ann Roder, a clinical nurse in the Gynecologic Oncology Outpatient Center at The University of Texas MD Anderson Cancer Center,...